ZNTL
#3413
Zentalis Pharmaceuticals, Inc. - common stock
3.8 0 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.06%
Monthly Change
-20.50%
6 month change
+61.70%
Year Change
+123.53%
Previous Close
3.8 8
Open
3.8 0
Low
3.8 0
High
3.8 0
Volume
27
Financials
- Market Capitalization 272.35 M
- Employee 106
- Founded 2014
- CEO N/A
- Website www.zentalis.com
- Headquarter California, United States
- FIGI BBG00R2K8TF5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.71
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3397 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 2.00 USD | -2.44% | -1.48% | +3.09% | +76.99% | 276.55 M USD | ||
| 3411 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.00 USD | -3.71% | -7.65% | +6.87% | +0.43% | 272.56 M USD | ||
| 3419 |  ACIU AC Immune SA - Common Stock | 2.65 USD | -2.21% | -8.93% | +15.22% | +27.40% | 269.62 M USD | ||
| 3420 |  PYXS Pyxis Oncology, Inc. - Common Stock | 3.23 USD | -2.71% | +6.95% | +9.49% | +152.34% | 269.41 M USD |
Frequently asked questions about Zentalis Pharmaceuticals, Inc. Common Stock
What is the Zentalis Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is 3.80. Over the past 24 hours, the stock has changed by -2.06%. Follow the ZNTL chart for real-time price dynamics.
What is the stock ticker of Zentalis Pharmaceuticals, Inc. Common Stock?
Zentalis Pharmaceuticals, Inc. Common Stock trades under the ticker ZNTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zentalis Pharmaceuticals, Inc. Common Stock stock going up?
ZNTL has changed by -1.55% over the last week, -20.50% over the last month, and +123.53% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Zentalis Pharmaceuticals, Inc. Common Stock?
Zentalis Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 272.35 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Zentalis Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Zentalis Pharmaceuticals, Inc. Common Stock reported earnings of -0.59 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Zentalis Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Zentalis Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 300 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Zentalis Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Zentalis Pharmaceuticals, Inc. Common Stock reported net income of -42.29 M for the last quarter. The previous quarter showed -35.35 M, which means net income changed by -19.61%.
How many employees does Zentalis Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Zentalis Pharmaceuticals, Inc. Common Stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is Zentalis Pharmaceuticals, Inc. Common Stock EBITDA?
Zentalis Pharmaceuticals, Inc. Common Stock EBITDA is -43.94 M, and its EBITDA margin is -14.65 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Zentalis Pharmaceuticals, Inc. Common Stock stock?
You can buy Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zentalis Pharmaceuticals, Inc. Common Stock stock?
Investing in Zentalis Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZNTL chart and related analysis on metatrader.com as part of your research.